D-0301-2026 Class II Ongoing
FDA drug recall D-0301-2026 was initiated by Unichem Pharmaceuticals USA Inc. on Jan 21, 2026 and is designated Class II. Reason for recall: cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits. The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 11, 2026
- Initiation Date
- Jan 21, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC., East Brunswick, NJ 08816, NDC 29300-187-01
Reason for recall
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
Distribution pattern
US Nationwide and PR.
Code information
Lot # GBHL24005A, Exp Date: 09/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0301-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026